This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Seikagaku Corporation. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Tomochika Kisukeda: Innovator in Glycosaminoglycan Derivatives
Introduction: Tomochika Kisukeda is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work involving glycosaminoglycan derivatives. His research has the potential to impact various therapeutic applications.
Latest Patents: Tomochika Kisukeda holds 1 patent for his invention titled "Composition including glycosaminoglycan derivative and chemokine receptor activity regulator." This patent provides a composition comprising a GAG derivative and a chemokine receptor activity regulator, along with a pharmaceutical composition that includes this innovative combination.
Career Highlights: Kisukeda is associated with Seikagaku Corporation, a company known for its focus on glycoscience and innovative therapeutic solutions. His work at Seikagaku has allowed him to explore and develop new pharmaceutical compositions that could lead to advancements in medical treatments.
Collaborations: Throughout his career, Tomochika has collaborated with esteemed colleagues such as Yuichi Chikaraishi and Yasuhiro Goto. These collaborations have fostered a productive environment for research and innovation in the field of glycosaminoglycans.
Conclusion: Tomochika Kisukeda's contributions to the field of glycosaminoglycan derivatives exemplify the importance of innovation in pharmaceuticals. His work continues to pave the way for new therapeutic possibilities, showcasing the impact of dedicated inventors in advancing medical science.